Search research articles
Contact Us
Filters
Showing results (21-30 of 28) with videos related to
Page
of 3
Sort By:
You have reached the last page of results.
This site can display upto 28 results.
Nature Communications
|
August 21, 2025
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition
Femke C A S Ringnalda, Gijs J F van Son, Laurens H G Verweij, et al.
EMBO Molecular Medicine
|
August 2, 2022
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
Michael T Meister, Marian J A Groot Koerkamp, Terezinha de Souza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial
Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
Science Advances
|
February 6, 2021
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell
Gerda Kildisiute, Waleed M Kholosy, Matthew D Young, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Karin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Cancer Cell
|
January 5, 2024
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy
Judith Wienke, Lindy L Visser, Waleed M Kholosy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 1, 2022
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'
Karin P S Langenberg, Michael T Meister, Jette J Bakhuizen, et al.
Cancer Discovery
|
August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
Cornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Page
of 3
Search research articles
Search
Showing results (21-30 of 28) with videos related to
Sort By:
Page
of 3
You have reached the last page of results.
This site can display upto 28 results.
Nature Communications
|
August 21, 2025
Small round cell sarcoma tumoroid biobank reveals CIC::DUX4 sarcoma vulnerability to MCL-1 inhibition
Femke C A S Ringnalda, Gijs J F van Son, Laurens H G Verweij, et al.
EMBO Molecular Medicine
|
August 2, 2022
Mesenchymal tumor organoid models recapitulate rhabdomyosarcoma subtypes
Michael T Meister, Marian J A Groot Koerkamp, Terezinha de Souza, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research
|
January 27, 2026
Phase I/II study of the PARP inhibitor olaparib and irinotecan in children and young adults with recurrent/refractory malignancies: Arm D of the AcSé-ESMART trial
Susanne A Gatz, Pablo Berlanga, Gwénaël Le Teuff, et al.
Science Advances
|
February 6, 2021
Tumor to normal single-cell mRNA comparisons reveal a pan-neuroblastoma cancer cell
Gerda Kildisiute, Waleed M Kholosy, Matthew D Young, et al.
European Journal of Cancer (Oxford, England : 1990)
|
February 15, 2025
Exploring high-throughput drug sensitivity testing in neuroblastoma cell lines and patient-derived tumor organoids in the era of precision medicine
Karin P S Langenberg, Sander R van Hooff, Bianca Koopmans, et al.
Cancer Cell
|
January 5, 2024
Integrative analysis of neuroblastoma by single-cell RNA sequencing identifies the NECTIN2-TIGIT axis as a target for immunotherapy
Judith Wienke, Lindy L Visser, Waleed M Kholosy, et al.
European Journal of Cancer (Oxford, England : 1990)
|
October 1, 2022
Implementation of paediatric precision oncology into clinical practice: The Individualized Therapies for Children with cancer program 'iTHER'
Karin P S Langenberg, Michael T Meister, Jette J Bakhuizen, et al.
Cancer Discovery
|
August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence Targets
Cornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Page
of 3